The link between the multiverse of immune microenvironments in metastases and the survival of colorectal cancer patients M Van den Eynde, B Mlecnik, G Bindea, T Fredriksen, SE Church, ... Cancer cell 34 (6), 1012-1026. e3, 2018 | 246 | 2018 |
T-cell responses to survivin in cancer patients undergoing radiation therapy D Schaue, B Comin-Anduix, A Ribas, L Zhang, L Goodglick, JW Sayre, ... Clinical Cancer Research 14 (15), 4883-4890, 2008 | 163 | 2008 |
Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer A Debucquoy, K Haustermans, A Daemen, S Aydin, L Libbrecht, ... Journal of Clinical Oncology 27 (17), 2751-2757, 2009 | 137 | 2009 |
Radiotherapy-activated cancer-associated fibroblasts promote tumor progression through paracrine IGF1R activation J Tommelein, E De Vlieghere, L Verset, E Melsens, J Leenders, ... Cancer research 78 (3), 659-670, 2018 | 131 | 2018 |
A kernel-based integration of genome-wide data for clinical decision support A Daemen, O Gevaert, F Ojeda, A Debucquoy, JAK Suykens, C Sempoux, ... Genome medicine 1, 1-17, 2009 | 100 | 2009 |
Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers L Goethals, A Debucquoy, C Perneel, K Geboes, N Ectors, H De Schutter, ... International Journal of Radiation Oncology* Biology* Physics 65 (1), 246-254, 2006 | 89 | 2006 |
A new approach to the validation of tissue microarrays L Goethals, C Perneel, A Debucquoy, H De Schutter, D Borghys, N Ectors, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2006 | 86 | 2006 |
Predicting the tumor response to chemoradiotherapy for rectal cancer: model development and external validation using MRI radiomics P Bulens, A Couwenberg, M Intven, A Debucquoy, V Vandecaveye, ... Radiotherapy and Oncology 142, 246-252, 2020 | 76 | 2020 |
Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in locally advanced rectal cancer PP Grimminger, P Danenberg, K Dellas, D Arnold, C Rödel, JP Machiels, ... Clinical Cancer Research 17 (10), 3469-3477, 2011 | 66 | 2011 |
Double blind randomized phase II study with radiation+ 5-fluorouracil±celecoxib for resectable rectal cancer A Debucquoy, S Roels, L Goethals, L Libbrecht, E Van Cutsem, K Geboes, ... Radiotherapy and Oncology 93 (2), 273-278, 2009 | 66 | 2009 |
EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients S Hu-Lieskovan, D Vallbohmer, W Zhang, D Yang, A Pohl, MJ Labonte, ... Clinical Cancer Research 17 (15), 5161-5169, 2011 | 57 | 2011 |
Molecular responses of rectal cancer to preoperative chemoradiation A Debucquoy, L Goethals, K Geboes, S Roels, WH Mc Bride, ... Radiotherapy and oncology 80 (2), 172-177, 2006 | 57 | 2006 |
Integrating microarray and proteomics data to predict the response on cetuximab in patients with rectal cancer A Daemen, O Gevaert, T De Bie, A Debucquoy, JP Machiels, B De Moor, ... Biocomputing 2008, 166-177, 2008 | 54 | 2008 |
Quantitative imaging outperforms molecular markers when predicting response to chemoradiotherapy for rectal cancer I Joye, A Debucquoy, CM Deroose, V Vandecaveye, E Van Cutsem, ... Radiotherapy and Oncology 124 (1), 104-109, 2017 | 45 | 2017 |
Molecular and clinico-pathological markers in rectal cancer: a tissue micro-array study A Debucquoy, L Goethals, L Libbrecht, C Perneel, K Geboes, N Ectors, ... International journal of colorectal disease 24, 129-138, 2009 | 43 | 2009 |
Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR‐TREC)? Protocol … SP Bach, STAR‐TREC Collaborative Colorectal Disease 24 (5), 639-651, 2022 | 42 | 2022 |
Extending the minimum information about biobank data sharing terminology to describe samples, sample donors, and events N Eklund, NH Andrianarisoa, E van Enckevort, G Anton, A Debucquoy, ... Biopreservation and biobanking 18 (3), 155-164, 2020 | 41 | 2020 |
Integration of epidermal growth factor receptor inhibitors with preoperative chemoradiation A Debucquoy, JP Machiels, WH McBride, K Haustermans Clinical Cancer Research 16 (10), 2709-2714, 2010 | 35 | 2010 |
Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial M Verstraete, A Debucquoy, J Dekervel, J Van Pelt, C Verslype, E Devos, ... British journal of cancer 112 (8), 1314-1325, 2015 | 31 | 2015 |
Morphological features and molecular markers in rectal cancer from 95 patients included in the European Organisation for Research and Treatment of Cancer 22921 trial … A Debucquoy, L Libbrecht, V Roobrouck, L Goethals, W McBride, ... European Journal of Cancer 44 (6), 791-797, 2008 | 31 | 2008 |